This marks Vetter’s fourth internationally recognized award for its syringe closure system, Vetter-Ject.
Vetter, an international contract development and manufacturing organization (CDMO) focused on the production of aseptically prefilled syringes, was awarded the World Packaging Organization’s (WPO) WorldStar award 2016 for the company’s syringe closure system Vetter-Ject. This marks the fourth award Vetter has received for the system, including the iF Design Award, the Red Dot Award, and the German Packaging Award.
According to WPO, the WorldStar awards “are presented only to those packages which, having already won recognition in a national competition are compared by an expert panel of judges to similar packages from around the world.” In a press announcement from Vetter, the company explains representatives from 19 packaging associations judged 293 projects entered into the WorldStar competition from 35 countries. Vetter previously won the WorldStar award in 1998 for the Vetter Lyo-Ject dual chamber syringe.
Vetter also announced that the company received a 2016 CMO Leadership Award from Life Science Leader magazine. The company was named a winner in four categories including quality, capabilities, expertise, and compatibility.
Source: Vetter
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.